305 filings
Page 3 of 16
UPLOAD
pzp0v iks
7 Nov 23
Letter from SEC
12:00am
4
vum2l26ef6egnzudcs
3 Nov 23
SAB Biotherapeutics / Michael King ownership change
4:50pm
3
n6it7mmibi9wwc ck6ou
3 Nov 23
SAB Biotherapeutics / Michael King ownership change
4:40pm
8-K
pwhkyiedo3 o9y
27 Oct 23
Entry into a Material Definitive Agreement
5:00pm
4
kgz43qh1 5di770abme
24 Oct 23
SAB Biotherapeutics / John Petry ownership change
5:33pm
4
i8tek0q11jiiax8
24 Oct 23
SAB Biotherapeutics / Andrew Moin ownership change
5:30pm
PRE 14A
bpaqr0plw 4z0i6xivef
20 Oct 23
Preliminary proxy
4:30pm
D
49b6rsbc7zzpj3od
16 Oct 23
$7.50 mm in equity / options, sold $7.50 mm, 13 investors
4:08pm
SC 13G
vbgl3y
16 Oct 23
SAB Biotherapeutics / COMMODORE CAPITAL ownership change
4:05pm
3
vd1fth
10 Oct 23
SAB Biotherapeutics / John Petry ownership change
4:24pm
3
rsrrn1vnmywi
10 Oct 23
SAB Biotherapeutics / Andrew Moin ownership change
4:05pm
8-K
e1nw3 vnuwno
2 Oct 23
SAB Biotherapeutics Announces Private Placement of up to $130 Million to Advance Development of Lead Drug Candidate for Type 1 Diabetes
4:10pm
UPLOAD
m9we2 qur4oor9
27 Sep 23
Letter from SEC
12:00am
CORRESP
cs08czj
26 Sep 23
Correspondence with SEC
12:00am
UPLOAD
s9hqy
25 Sep 23
Letter from SEC
12:00am
EFFECT
bk4v0f jivr79xo8ru
31 Aug 23
Notice of effectiveness
12:15am
CORRESP
qysh obwuy2rj7a
28 Aug 23
Correspondence with SEC
12:00am